A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.

Size: px
Start display at page:

Download "A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer."

Transcription

1 Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine is a secretagogue for stomach acid, but this is not the only correct answer. Gastrin is a secretagogue for stomach acid, but this is not the only correct answer. PGE1 inhibits stomach acid secretion. D. Correct! Histamine and gastrin are both secretagogues for stomach acid. PGE1 inhibits stomach acid secretion. Acid is secreted from gastric parietal cells by a proton pump (K/H-ATPase). The three endogenous secretagogues for acid are histamine, acetylcholine and gastrin. PGE2 and PGE1 inhibit acid and stimulate mucus and bicarbonate secretion. The correct answer is (D).

2 No. 2 of 10 Instructions: (1) Read the problem and answer choices carefully (2) Work the problems on paper as needed (3) Pick the answer (4) Go back to review the core concept tutorial as needed. 2. Anatacids: #02 (A) Heal gastric ulcers (B) Heal duodoneal ulcers (C) Inhibit peptic activity (D) A and C (E) A, B and C Antacids heal gastric ulcers, but this is not their only action. B. Incrrect! Antacids do not heal duodoneal ulcers. Feedback on Each Answer Antacids inhibitr peptic activity, but this is not their only action. D. Correct! Antacids heal gastric ulcers and inhibit peptic activity. Antacids do not heal duodoneal ulcers. Antacids act by neutralizing acid and thus raise gastric ph. This has the effect of inhibiting peptic activity which practically ceases at ph 5. Given in sufficient quantity for long enough they can produce healing of gastric ulcers but not duodenal ulcers. The antacids commonly used include sodium bicarbonate, magnesium hydroxide and aluminum hydroxide. The correct answer is (D).

3 No. 3 of is a rapid acting antacid, which acts by releasing carbon dioxide. #03 (A) Magnesium hydroxide (B) Sodium bicarbonate (C) Aluminum hydroxide (D) Colloidal aluminum hydroxide (E) Sucaralfate Magnesium hydroxide is an insoluble powder which reacts slowly with the gastric juice forming magnesium chloride in the stomach. B. Correct! Sodium bicarbonate is a rapid acting antacid, which acts by releasing carbon dioxide. Aluminum hydroxide gel forms aluminum chloride in the stomach, when this reaches the intestine the chloride is released and is reabsorbed. Colloidal aluminum hydroxide combines with phosphates in the GIT and the increased excretion of phosphate in the feces which occurs results in the decreased excretion of phosphate via the kidney. Sucralfate is a complex of aluminum hydroxide and sulphated sucrose which has been shown to promote the healing of ulcers. Sodium bicarbonate acts rapidly and is said to raise the ph of gastric juice to about 7.4. Carbon dioxide is liberated, which eradicates gas. This evolution of CO 2 stimulates gastrin secretion and can result in the secondary rise in acid secretion. Since some sodium bicarbonate is adsorbed in the intestine, large doses or frequent administration can cause alkalosis The correct answer is (B).

4 No. 4 of Mucosal-protecting mechanisms include: #04 (A) Mucus (B) Bicarbonate (C) PGE1 (D) PGE2 (E) All of the above Mucus does protect the mucosal layer, but this is not the only correct answer. Bicarbonate does protect the mucosal layer, but this is not the only correct answer. PGE1 does protect the mucosal layer, but this is not the only correct answer. PGE2 does protect the mucosal layer, but this is not the only correct answer. E. Correct! Mucus-protecting mechanisms include mucus, bicarbonate, PGE1 and PGE2. Peptic ulcers are thought to be due to an imbalance between: Mucosal-damaging mechanisms (Acid, pepsin) and Mucosal-protecting mechanisms (mucus, bicarbonate, local synthesis of PGE1 and PGE2). The correct answer is (E).

5 No. 5 of Agents that affect gastric secretion of acid include: #05 (A) Proton pump inhibitors (B) H2 receptor antagonists (C) Sucralfate (D) A and B (E) A, B and C Proton pump inhibitors reduce gastric secretion of acid, but this is not the only correct answer. H2 receptor antagonists reduce gastric secretion of acid, but this is not the only correct answer. Sucralfate stimulates mucus and bicarbonate secretion and prostaglandin production. D. Correct! Agents that affect gastric secretion of acid include proton pump inhibitors and H2 receptor antagonists. Sucralfate stimulates mucus and bicarbonate secretion and prostaglandin production. The two primary classes of drugs that affect gastric secretion are H2 receptor antagonists, including cimetidine, ranitidine, famotidine and nizatidine, and proton pump inhibitors. The correct answer is (D).

6 No. 6 of Omeprazole is: #06 (A) Proton pump inhibitors (B) Antacids (C) PGE1 (D) Antibiotics (E) Motility stimulants A. Correct! Omeprazole is a proton pump inhibitor. Think of drugs that decrease acid production. Prostaglandin E1 is a protective mechanism. Think of drugs that decrease acid production. Think of drugs that decrease acid production. Proton Pump Inhibitors degrade rapidly at low ph; they are administered as capsules containing enteric-coated granules to prevent inactivation in the stomach. The class of drugs known as proton pump inhibitors includes: Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole, and Esomeprazole. The correct answer is (A).

7 No. 7 of 10 as needed (3) Pick the answer (4) Go back to review the core concept tutorial as needed. 7. agents not only decrease both basal and food-stimulated acid secretion by 90% or more, but promote healing of duodenal ulcers. #07 (A) Proton pump inhibitors (B) Antacids (C) H2 receptor antagonists (D) Antibiotics (E) Motility stimulants Proton pump inhibitors should be taken on an empty stomach. Antacids do not heal duodoneal ulcers. C. Correct! H2 receptor antagonists not only decrease both basal and food-stimulated acid secretion by 90% or more, but promote healing of duodenal ulcers. Antibiotics do not affect gastric acid secretion. Motility stimulants do not affect gastric acid secretion. H2 receptor antagonists not only decrease both basal and food-stimulated acid secretion by 90% or more, but promote healing of duodenal ulcers, as shown by numerous clinical trials. Relapses are likely to follow when treatment with H2- receptor antagonists is stopped. The correct answer is (C).

8 No. 8 of Sucralfate: #08 (A) Stimulates the mucosal protecting mechanisms. (B) Promotes the healing of ulcers. (C) Is a complex of aluminum hydroxide and sulphated sucrose. (D) A and C (E) A, B and C Sucralfate stimulates the mucosal protecting mechanisms, but this is not its only action. Sucralfate promotes the healing of ulcers, but this is not its only action. Sucralfate is a complex of aluminum hydroxide and sulphated sucrose, but this is not its only characteristic. More than just A and C are correct. E. Correct! Sucralfate stimulates the mucosal protecting mechanisms, promotes the healing of ulcers and is a complex of aluminum hydroxide and sulphated sucrose. Sucralfate is a complex of aluminum hydroxide and sulphated sucrose which has been shown to promote the healing of ulcers. In the presence of acid, sucralfate releases aluminum, acquires a strong negative charge and binds to positively charged groups in proteins, glycoproteins etc. It adheres to both damaged normal mucosa. It can form complex gels with mucus, and action which is thought to decrease the degradation of mucus by pepsin and to limit the diffusion of hydrogen ions. It stimulates the mucosal protecting mechanisms- mucus and bicarbonate secretion and prostaglandin production. The correct answer is (E).

9 No. 9 of Misoprostol is a stable analogue for: #09 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Think of an inhibitor of gastric acid secretion. Think of an inhibitor of gastric acid secretion. C. Correct! Misoprostol is a stable analogue for prostaglandin E1. Think of an inhibitor of gastric acid secretion. Think of an inhibitor of gastric acid secretion. Misoprostol is a stable analogue for prostaglandin E1. It inhibits gastric acid secretion both basal and that occurring in response to food, histamine, pentagastrin and caffeine by a direct action on the parietal cell. It maintains or increases mucosal blood flow and increases the secretion of mucus and bicarbonate. The correct answer is (C).

10 No. 10 of 10 as needed (3) Pick the answer (4) Go back to review the core concept tutorial as needed. 10. Domperidone acts at: #10 (A) D1 dopamine receptors. (B) D2 dopamine receptors. (C) H1 histamine receptors. (D) H2 histamine receptors. (E) Serotonin receptors. Think of a different dopamine receptor. B. Correct! Domperidone is a dopamine receptor antagonist acting at D2-receptors and is used as an anti-emetic. Try one of the dopamine receptors. Try one of the dopamine receptors. Try one of the dopamine receptors. Domperidone is a dopamine receptor antagonist acting at D2-receptors and is used as an anti-emetic. It is also effective in increasing gastrointestinal motility. Clinically it increases lower esophageal sphincter pressure, increases gastric emptying and enhances duodenal peristalsis. It does not stimulate gastric acid secretion. It is useful in disorders of gastric emptying and in chronic gastric reflux. The correct answer is (B).

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018 GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs

More information

Second term/

Second term/ Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic

More information

-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e

-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e -1 -Mohammad Ashraf -Anas Raed -Alia Shatnawi 1 P a g e Dr. Alia started the lecture by talking about subjects we are going to cover through this course; you can refer to the record if you are interested.

More information

OSPAP Programme. Gastrointestinal Drugs. Dr. Adrian Moore Dale

OSPAP Programme. Gastrointestinal Drugs. Dr. Adrian Moore Dale PAP Programme Dr. Adrian Moore Dale 1.03 Adrian.Moore@sunderland.ac.uk 0191 5152554 lide 1 of 26 PAP MPM14 Acid-Related Pathophysiology The stomach secretes: ydrochloric acid (Cl) aids digestion and also

More information

Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases

Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases p1009 DRUGS USED IN ACID-PEPTIC DISEASES 1. classification of drugs 2. agents that reduce intragastric acidity Antacids,H 2 antagonists,proton

More information

Copy right protected Page 1

Copy right protected Page 1 DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.

More information

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:

More information

Lab:2 Drugs acting on Gastrointestinal tract

Lab:2 Drugs acting on Gastrointestinal tract Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced

More information

Antacid therapy: Antacids side effects:

Antacid therapy: Antacids side effects: Antacids Lec:5 When the general public ask why it takes antacids, the answer will include: 1.that uncomfortable feeling from overeating. 2. heart burn. 3. a growing hungry feeling between meals. Antacids

More information

Peptic ulcer disease Disorders of the esophagus

Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth

More information

- Ali Yaghi. - Sara Yaghi. - Alia Shatnawi. 1 P a g e

- Ali Yaghi. - Sara Yaghi. - Alia Shatnawi. 1 P a g e -2 - Ali Yaghi - Sara Yaghi - Alia Shatnawi 1 P a g e We ended the previous lecture with H2 receptor antagonists, which work by selectively inhibiting H2 receptors. They are widely used to treat: 1- GERD,

More information

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018 GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Z Gastroenterol. 1983 Mar;21 Suppl:111-6. [Effect of antacids on intestinal motility]. [Article in German] Wienbeck M, Erckenbrecht J, Strohmeyer G. Abstract

More information

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many

More information

Pthaigastro.org. Evolution of antisecretory agents. History. Antacids and anticholinergic drugs

Pthaigastro.org. Evolution of antisecretory agents. History. Antacids and anticholinergic drugs Evolution of antisecretory agents uthapong Ukarapol, MD. Division of Gastroenterology Chiang Mai University istory 1823- Prout discovered gastric hydrochloric acid 1875- eidenhain and 1893- Golgi identified

More information

Optimal Drugs for ICU Stress Ulcer Prophylaxis: Other. Grand Rounds Monday August 9, 2010 Teresa Jones R2

Optimal Drugs for ICU Stress Ulcer Prophylaxis: Other. Grand Rounds Monday August 9, 2010 Teresa Jones R2 Optimal Drugs for ICU Stress Ulcer Prophylaxis: Other Grand Rounds Monday August 9, 2010 Teresa Jones R2 Outline Options besides PPIs Comparison to PPIs Negative Effects of PPIs Conclusion Do we really

More information

Gastrointestinal Pharmacology

Gastrointestinal Pharmacology Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal

More information

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment

More information

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011 KK College of Nursing Peptic Ulcer Badil Dass, Lecturer 25 th July, 2011 Objectives: By the end of this lecture, the students t will be able to: Define peptic pp ulcer Describe the etiology and pathology

More information

Case 4: Peptic Ulcer Disease. Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie

Case 4: Peptic Ulcer Disease. Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie Case 4: Peptic Ulcer Disease Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie Case 4: PUD Problem List: 1. Peptic Ulcer Disease SOAP Note: S Patient is complaining of abdominal pain

More information

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty. Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form omeprazole

More information

Pharmacology. Drugs that Affect the Gastrointestinal System

Pharmacology. Drugs that Affect the Gastrointestinal System Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against

More information

Rpts. GENERAL General Schedule (Code GE)

Rpts. GENERAL General Schedule (Code GE) Pantoprazole 20mg Name, Restriction, Manner of administration and form Pantoprazole 20mg enteric tablet, 30 (8399C) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT "Carbellon" Tablets. 2. Qualitative and Quantitative Composition Active Constituents: Activated Charcoal Ph.Eur. Magnesium Hydroxide Ph.Eur.

More information

University of Buea. Faculty of Health Sciences. Programme in Medicine

University of Buea. Faculty of Health Sciences. Programme in Medicine Faculty of Health Sciences University of Buea Wednesday, 28 th January 2009 Time: 8 00-10 00 Programme in Medicine MED 303 (Gastrointestinal Physiology) EXAMS (2008-2009) Identify the letter of the choice

More information

5. Which component of the duodenal contents entering the stomach causes the most severe changes to gastric mucosa:

5. Which component of the duodenal contents entering the stomach causes the most severe changes to gastric mucosa: Gastro-intestinal disorders 1. Which are the most common causes of chronic gastritis? 1. Toxic substances 2. Chronic stress 3. Alimentary factors 4. Endogenous noxious stimuli 5. Genetic factors 2. Chronic

More information

Peptic ulcer disease 1 GIT. Dr Kawa Ahmad PhD Pharmaceutics

Peptic ulcer disease 1 GIT. Dr Kawa Ahmad PhD Pharmaceutics 51 Peptic ulcer disease Dr Kawa Ahmad PhD Pharmaceutics 1 GIT Food taken into the mouth is mixed with saliva to form a plastic mass. The salivary glands secrete about 1 L of fluid daily; this contains

More information

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.09.01 Subject: Proton Pump Inhibitors Page: 1 of 7 Last Review Date: June 12, 2014 Proton Pump Inhibitors

More information

Module 2 Heartburn Glossary

Module 2 Heartburn Glossary Absorption Antacids Antibiotic Module 2 Heartburn Glossary Barrett s oesophagus Bloating Body mass index Burping Chief cells Colon Digestion Endoscopy Enteroendocrine cells Epiglottis Epithelium Absorption

More information

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both

More information

August 2003 Peptic Ulcer Management H01

August 2003 Peptic Ulcer Management H01 W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL 60015 847-945-8050 August 2003 Peptic Ulcer Management 707-000-03-008-H01 MISSING A LESSON? IT S EASY TO GO TO OUR WEBSITE &

More information

Policy Evaluation: Proton Pump Inhibitors (PPIs)

Policy Evaluation: Proton Pump Inhibitors (PPIs) Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE Definition A circumscribed ulceration of the gastrointestinal mucosa occurring in areas exposed to acid and pepsin and most often caused

More information

Reflux of gastric contents, particularly acid, into the esophagus

Reflux of gastric contents, particularly acid, into the esophagus Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,

More information

Proton Pump Inhibitors. Description

Proton Pump Inhibitors. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.01 Subject: Proton Pump Inhibitors Page: 1 of 6 Last Review Date: June 24, 2015 Proton Pump Inhibitors

More information

Current Ideas of Causes and Management A.M. Merritt, DVM, MS Professor Emeritus, University of Florida

Current Ideas of Causes and Management A.M. Merritt, DVM, MS Professor Emeritus, University of Florida Current Ideas of Causes and Management A.M. Merritt, DVM, MS Professor Emeritus, University of Florida Some Essentials of Equine Gastric Anatomy and Function Relative to EGUS Anatomy In contrast to humans,

More information

Gastric Ulcer Prophylaxis in the Critically Ill Equine Neonate ( 6-Nov-2001 )

Gastric Ulcer Prophylaxis in the Critically Ill Equine Neonate ( 6-Nov-2001 ) In: Recent Advances in Equine Neonatal Care, P. A. Wilkins and J. E. Palmer (Eds.) Publisher: International Veterinary Information Service (www.ivis.org), Ithaca, New York, USA. Gastric Ulcer Prophylaxis

More information

Difference between omeprazole and omeprazole delayed release

Difference between omeprazole and omeprazole delayed release Cari untuk: Cari Cari Difference between omeprazole and omeprazole delayed release 7-2-2018 Easy to read patient leaflet for Omeprazole Delayed-Release Capsules. Includes indications, proper use, special

More information

SASKATCHEWAN REGISTERED NURSES ASSOCIATION

SASKATCHEWAN REGISTERED NURSES ASSOCIATION DEFINITION Reflux of gastric contents into the esophagus, which results in esophageal irritation or inflammation. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS Dysphagia (solid food, progressive)

More information

Drug Class Review on Proton Pump Inhibitors

Drug Class Review on Proton Pump Inhibitors Drug Class Review on Proton Pump Inhibitors Final Report Update 4 July 2006 Original Report Date: November 2002 Update 1 Report Date: April 2003 Update 2 Report Date: April 2004 Update 3 Report Date: May

More information

Our gut reactions to food or, gut reactions - to food

Our gut reactions to food or, gut reactions - to food Key concepts in Digestion. Our gut reactions to food or, gut reactions to food Prof. Barry Campbell Cellular & Molecular Physiology email: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl Swallowing

More information

Peptic Ulcer Disease: Zollinger-Ellison Syndrome

Peptic Ulcer Disease: Zollinger-Ellison Syndrome GASTROINTESTINAL PHYSIOLOGY 235 Case 41 Peptic Ulcer Disease: Zollinger-Ellison Syndrome Abe Rosenfeld, who is 47 years old, owns a house painting business with his brothers. The brothers pride themselves

More information

April 2006 Peptic Ulcer Disease Volume 28 Number 4. W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL

April 2006 Peptic Ulcer Disease Volume 28 Number 4. W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL 60015 847-945-8050 April 2006 Peptic Ulcer Disease 707-000-06-004-H01 FLORIDA PARTICIPANTS Be sure to provide your Florida License

More information

Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate

More information

Gastrointestinal Physiology

Gastrointestinal Physiology Gastrointestinal Physiology Digestion and Absorption Definition Digestion: i Food dis dissolved d and broken down. Physical digestion: Propulsion and mixing of food by muscle in the alimentary tract. Chemical

More information

National Digestive Diseases Information Clearinghouse

National Digestive Diseases Information Clearinghouse Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach

More information

National Digestive Diseases Information Clearinghouse

National Digestive Diseases Information Clearinghouse Gastritis National Digestive Diseases Information Clearinghouse What is gastritis? Gastritis is a condition in which the stomach lining known as the mucosa is inflamed, or swollen. The stomach lining contains

More information

March 2007 Review of GERD H01 HAVE YOU RECENTLY MOVED? PLEASE NOTIFY US.

March 2007 Review of GERD H01 HAVE YOU RECENTLY MOVED? PLEASE NOTIFY US. W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL 60015 847-945-8050 March 2007 Review of GERD 707-000-07-003-H01 FLORIDA PHARMACISTS---Be sure to provide your Florida License

More information

Gastric and Intestinal secretion

Gastric and Intestinal secretion Gastric and Intestinal secretion OBJECTIVES: 1. Describe the various types of gastric cells and the secretion of each cell type. 2. Mention the components of gastric juice and the function of each component.

More information

DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM

DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM Page 1 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM SUNALI MEHTA Histamines and antihistamines: Histamine means tissue amine and is present in ample amount in the lung, skin and GI tract mucosa. Mast cells,

More information

UPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD

UPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD UPPER GI DISEASES NUTR 2050 Nutrition for Nursing Professionals Mrs. Deborah A. Hutcheon, MS, RD, LD Lesson Objectives At the end of the lesson, the student will be able to: 1. Describe causes and contributing

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. PROTON PUMP INHIBITORS, NON-PREFERRED FORMS: ACIPHEX (rabeprazole sodium EC) oral tablet ACIPHEX SPRINKLE (rabeprazole sodium DR) oral capsule ESOMEPRAZOLE STRONTIUM (esomeprazole strontium DR) oral capsule

More information

SUCRALFATE TABLETS, USP

SUCRALFATE TABLETS, USP 1234567890 10 210002 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:

More information

Equine gastric ulcer syndrome

Equine gastric ulcer syndrome Vet Times The website for the veterinary profession https://www.vettimes.co.uk Equine gastric ulcer syndrome Author : Nicola Menzies-Gow Categories : Vets Date : October 17, 2011 Nicola Menzies-Gow discusses

More information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information James Paget University Hospitals NHS Foundation Trust Hiatus hernia Patient Information What is a hiatus hernia? A hiatus hernia can cause highly irritating stomach contents, such as acid, to move up into

More information

Overview of digestion or, gut reactions - to food

Overview of digestion or, gut reactions - to food Key concepts in Digestion. Indigestion module Overview of digestion or, gut reactions - to food Prof. Barry Campbell Gastroenterology Cellular & Molecular Physiology e-mail: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl

More information

The Stomach. Bởi: OpenStaxCollege

The Stomach. Bởi: OpenStaxCollege Bởi: OpenStaxCollege Although a minimal amount of carbohydrate digestion occurs in the mouth, chemical digestion really gets underway in the stomach. An expansion of the alimentary canal that lies immediately

More information

Week 12 - Outline. Outline. Digestive System I Major Organs. Overview of Digestive System

Week 12 - Outline. Outline. Digestive System I Major Organs. Overview of Digestive System Outline Week 12 - Digestive System I Major Organs Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Digestive Tract Function GI Tract Structure Regulation of the

More information

High use of maintenance therapy after triple therapy regimes in Ireland

High use of maintenance therapy after triple therapy regimes in Ireland High use of maintenance therapy after triple therapy regimes in Ireland K Bennett, H O Connor, M Barry, C O Morain, J Feely Department of Pharmacology & Therapeutics Department of Gastroenterology Trinity

More information

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease (GERD) Information for patients UHN Read this handout to learn about: What gastroesohageal reflux (GERD) is Signs and symptoms How your doctor will know if you have it Tests

More information

Overview of digestion or, gut reactions - to food

Overview of digestion or, gut reactions - to food 1 Key concepts in Digestion. Indigestion module Overview of digestion or, gut reactions to food Prof. Barry Campbell Gastroenterology Cellular & Molecular Physiology email: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl

More information

SUCRALFATE ISELPIN 1 g Tablet

SUCRALFATE ISELPIN 1 g Tablet 1.0 PHARMACOLOGIC CATEGORY CYTOPROTECTOR 2.0 DESCRIPTION SUCRALFATE ISELPIN 1 g Tablet Sucralfate is a white, amorphous powder which is soluble in strong acids and in alkalis but practically insoluble

More information

Digestive System Module 4: The Stomach *

Digestive System Module 4: The Stomach * OpenStax-CNX module: m49286 1 Digestive System Module 4: The * Donna Browne Based on The by OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 4.0

More information

GASTROINTESTINAL MEDICATIONS By: Jerald S. Ugdoracion, RN, MN-MS

GASTROINTESTINAL MEDICATIONS By: Jerald S. Ugdoracion, RN, MN-MS GASTROINTESTINAL MEDICATIONS By: Jerald S. Ugdoracion, RN, MN-MS Reviewing these things may help you in understanding better how gastrointestinal medications alleviate problems of the GI tract: a. Review

More information

PRODUCT REPORT. PTM Food Consulting Inc. 38 Industrial Way E. Suite 7 Eatontown, N.J

PRODUCT REPORT. PTM Food Consulting Inc. 38 Industrial Way E. Suite 7 Eatontown, N.J MARCH 2007 JAVACID PRODUCT REPORT PTM Food Consulting Inc. 38 Industrial Way E. Suite 7 Eatontown, N.J. 07724 732.693.1516 www.foodconsultant.biz The Importance Of Acid / Alkaline Balance Over acidity,

More information

Nexium 24HR. Tools and information for you and your pharmacy team NOW OTC FOR FREQUENT HEARTBURN. Consumer Healthcare Pfizer Inc.

Nexium 24HR. Tools and information for you and your pharmacy team NOW OTC FOR FREQUENT HEARTBURN. Consumer Healthcare Pfizer Inc. NOW OTC FOR FREQUENT HEARTBURN w e N Nexium 24HR P H A R M A S S I S T K I T Tools and information for you and your pharmacy team 2014 Pfizer Inc. NXM041468 05/14 Q: What is the indication for Nexium 24HR

More information

Chapter 20 The Digestive System Exam Study Questions

Chapter 20 The Digestive System Exam Study Questions Chapter 20 The Digestive System Exam Study Questions 20.1 Overview of GI Processes 1. Describe the functions of digestive system. 2. List and define the four GI Processes: 20.2 Functional Anatomy of the

More information

Do You Know Your SATs? (Sugar, Acid blockers, Thinners) Laura Habighorst RN CAPA CGRN Heartland SGNA Spring Conference 2014

Do You Know Your SATs? (Sugar, Acid blockers, Thinners) Laura Habighorst RN CAPA CGRN Heartland SGNA Spring Conference 2014 Do You Know Your SATs? (Sugar, Acid blockers, Thinners) Laura Habighorst RN CAPA CGRN Heartland SGNA Spring Conference 2014 Objectives Describe the anesthesia contraindications for the administration of

More information

Soft palate elevates, closing off the nasopharynx. Hard palate Tongue Bolus Epiglottis. Glottis Larynx moves up and forward.

Soft palate elevates, closing off the nasopharynx. Hard palate Tongue Bolus Epiglottis. Glottis Larynx moves up and forward. The Cephalic Phase Chemical and mechanical digestion begins in the mouth Saliva is an exocrine secretion Salivary secretion is under autonomic control Softens and lubricates food Chemical digestion: salivary

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author: John Williams, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

Major intra and extracellular ions Lec: 1

Major intra and extracellular ions Lec: 1 Major intra and extracellular ions Lec: 1 The body fluids are solutions of inorganic and organic solutes. The concentration balance of the various components is maintained in order for the cell and tissue

More information

Inflammation of the Esophagus (Esophagitis) Basics

Inflammation of the Esophagus (Esophagitis) Basics Inflammation of the Esophagus (Esophagitis) Basics OVERVIEW Inflammation of the esophagus typically involves the tubular area of the esophagus itself (known as the esophageal body ) and the muscular area

More information

SUCRALFATE TABLETS, USP

SUCRALFATE TABLETS, USP 1234567890 10 210002-01 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:

More information

GI Secretion 1: Salivary and Gastric Secretion Jack Grider, Ph.D.

GI Secretion 1: Salivary and Gastric Secretion Jack Grider, Ph.D. GI Secretion 1: Salivary and Gastric Secretion Jack Grider, Ph.D. OBJECTIVES: 1. List the volumes of secretion by various regions. 2. Predict the components of salivary secretion at different flow rates.

More information

.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch.

.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch. .Drugs and the gastrointestinal system Chapter 11 11.1 Gastric acid-related conditions 149 11.2 Nausea and vomiting 153 11.3 Disorders of the bowel 155 11.4 Gallstones 156 Self-assessment on Chapter 11:

More information

Digestive System. - Food is ingested

Digestive System. - Food is ingested 11 V. Digestive Processes in the Mouth - Food is ingested - Mechanical digestion begins (chewing) - Salivary amylase begins chemical breakdown of starch - Propulsion is initiated by Deglutition (Swallowing)

More information

National Digestive Diseases Information Clearinghouse

National Digestive Diseases Information Clearinghouse Barrett s Esophagus National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is Barrett s esophagus? Barrett s esophagus is

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Achalasia, barium esophagography for, 57 58 Acid pocket, 18 19 Acid-sensing ion, 20 Acupuncture, 128 Adiponectin, in obesity, 166 ADX10059 metabotropic

More information

Section Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, ,

Section Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, , IDP Biological Systems Gastrointestinal System Section Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, 504-568-2669, jbresl@lsuhsc.edu Overall Learning Objectives 1. Characterize

More information

All Indiana Medicaid Prescribers and Pharmacy Providers

All Indiana Medicaid Prescribers and Pharmacy Providers P R O V I D E R B U L L E T I N BT200148 NOVEMBER 28, 2001 To: All Indiana Medicaid Prescribers and Pharmacy Providers Subject: Note: The information in this bulletin regarding prior authorization payment

More information

Understandings, Applications & Skills

Understandings, Applications & Skills D.2 Digestion Understandings, Applications & Skills Statement D.2.U1 Nervous and hormonal mechanisms control the secretion of digestive juices. D.2.U2 Exocrine glands secrete to the surface of the body

More information

GASTROESOPHAGEAL REFLUX DISEASE. William M. Brady

GASTROESOPHAGEAL REFLUX DISEASE. William M. Brady Drugs of Today 1998, 34(1): 25-30 Copyright PROUS SCIENCE GASTROESOPHAGEAL REFLUX DISEASE William M. Brady Section of General Internal Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania,

More information

Acid-Base Balance 11/18/2011. Regulation of Potassium Balance. Regulation of Potassium Balance. Regulatory Site: Cortical Collecting Ducts.

Acid-Base Balance 11/18/2011. Regulation of Potassium Balance. Regulation of Potassium Balance. Regulatory Site: Cortical Collecting Ducts. Influence of Other Hormones on Sodium Balance Acid-Base Balance Estrogens: Enhance NaCl reabsorption by renal tubules May cause water retention during menstrual cycles Are responsible for edema during

More information

Impact factor: 3.958/ICV: 4.10 ISSN:

Impact factor: 3.958/ICV: 4.10 ISSN: Impact factor: 3.958/ICV: 4.10 ISSN: 0976-7908 210 Pharma Science Monitor 8(2), Apr-Jun 2017 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com

More information

Chapter 20 The Digestive System Exam Study Questions

Chapter 20 The Digestive System Exam Study Questions Chapter 20 The Digestive System Exam Study Questions 20.1 Overview of GI Processes 1. Describe the functions of digestive system. 2. List and define the four GI Processes: 20.2 Functional Anatomy of the

More information

Fundamentals of Pharmacology for Veterinary Technicians Chapter 4

Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 (A) (B) Figure 4-1 A, B (C) FIGURE 4-1C The active transport process moves particles against the concentration gradient from a region of low concentration to a region of high concentration. Active transport

More information

235 60th Street, West New York, NJ T: (201) F: (201) Main Street, Hackensack, NJ T: (201)

235 60th Street, West New York, NJ T: (201) F: (201) Main Street, Hackensack, NJ T: (201) 235 60th Street, West New York, NJ 07093 T: (201) 854-4646 F: (201) 854-4647 810 Main Street, Hackensack, NJ 07601 T: (201) 488-0095 Barrett's Esophagus WHAT IS BARRETTT'S ESOPHAGUS? Barrett's esophagus

More information

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease (Review)

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease (Review) Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease (Review) Donnellan C, Sharma N, Preston C, Moayyedi P This is a reprint of a Cochrane review,

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 14 September 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 14 September 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 14 September 2011 GAVISCON PEPPERMINT, chewable tablet B/20 (CIP code: 367 909-6) GAVISCON, oral suspension 250 ml

More information

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small Lecture-5 1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small intestine. Because the duodenum has the greatest

More information

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials. Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs

More information

PRODUCT INFORMATION AUSRAN. (150 mg and 300 mg TABLETS)

PRODUCT INFORMATION AUSRAN. (150 mg and 300 mg TABLETS) PRODUCT INFORMATION AUSRAN (150 mg and 300 mg TABLETS) NAME OF MEDICINES AUSRAN tablets contain ranitidine hydrochloride. Its chemical structure is represented below: CAS No.: 66357-59-3 Empirical Formula:

More information

Mosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2

Mosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN Types of Acid-Controlling Agents Antacids H 2 antagonists Proton pump inhibitors Mosby items and derived items 2005,

More information

NON STEROIDAL ANTI INFLAMMATORY NSAID

NON STEROIDAL ANTI INFLAMMATORY NSAID NON STEROIDAL ANTI INFLAMMATORY DRUGS NSAID inflammation Normal, protective response to tissue injury 1-physical trauma 2-noxious chemical 3-microbial agent NSAIDs act by inhibiting the synth. Of prostaglandins

More information

ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats

ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats Received: 1 August 2018 Accepted: 5 September 2018 DOI: 10.1111/jvim.15337 CONSENSUS STATEMENT Consensus Statements of the American College of Veterinary Internal Medicine (ACVIM) provide the veterinary

More information

Package leaflet: Information for the user. EDURANT 25 mg film-coated tablets rilpivirine

Package leaflet: Information for the user. EDURANT 25 mg film-coated tablets rilpivirine Package leaflet: Information for the user EDURANT 25 mg film-coated tablets rilpivirine Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Epidemiology of Peptic Ulcer Disease

Epidemiology of Peptic Ulcer Disease Epidemiology of Peptic Ulcer Disease Introduction Peptic Ulcer Disease (PUD) is disruption of the mucosal integrity of the stomach and/or duodenum leading to a local defect or excavation due to active

More information

Station 1. Identify (= name) the spaces or structures labeled 1 9.

Station 1. Identify (= name) the spaces or structures labeled 1 9. Station 1. Identify (= name) the spaces or structures labeled 1 9. 1 9 8 2 7 3 4 5 6 Station 2. Identify/name the parts or structures labeled 10 20. 10. Is this the right or left lung? 15 13 14 16 11 12

More information

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)?

CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? A. Chronic alcohol ingestion B. Nonsteroidal antiinflammatory

More information